LANCET ONCOL - The lancet oncology

Bibliografische Daten

ISSNs	1470-2045
Elektronische ISSN	1474-5488

International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

Rodriguez-Otero, P., Usmani, S., Cohen, A. D., van de Donk, N. W. C. J., Leleu, X., Pérez-Larraya, J. G., Manier, S., Nooka, A. K., Mateos, M. V., Einsele, H., Minnema, M., Cavo, M., Derman, B. A., Puig, N., Gay, F., Ho, P. J., Chng, W-J., Kastritis, E., Gahrton, G., Weisel, K., Nagarajan, C., Schjesvold, F., Mikhael, J., Costa, L., Raje, N. S., Zamagni, E., Hájek, R., Weinhold, N., Yong, K., Ye, J. C., Sidhana, S., Merlini, G., Martin, T., Lin, Y., Chari, A., Popat, R., Kaufman, J. L. & International Myeloma Working Group, 05.2024, in: LANCET ONCOL. 25, 5, S. e205-e216

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine

Salek, M., Mueller, A., Alanbousi, I., Cepowska, Z., Dutkiewicz, M., Earl, J., Evseev, D., Kizyma, R., Kliuchkivska, K., Kolodrubiec, J., Matczak, K., Nogovitsyna, Y., Oszer, A., Pogorelyy, M., Raciborska, A., Rasul, S., Sokolowski, I., Sopilnyak, A., Vinitsky, A., Wlodarski, M. W., Wobst, N., Yakimkova, T., Rodriguez-Galindo, C., Wise, P. H., Mlynarski, W., Agulnik, A. & SAFER Ukraine Collaborative, 12.2023, in: LANCET ONCOL. 24, 12, S. 1315-1318 4 S.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups

Karschnia, P., Smits, M., Reifenberger, G., Le Rhun, E., Ellingson, B. M., Galldiks, N., Kim, M. M., Huse, J. T., Schnell, O., Harter, P. N., Mohme, M., von Baumgarten, L., Albert, N. L., Huang, R. Y., Mehta, M. P., van den Bent, M., Weller, M., Vogelbaum, M. A., Chang, S. M., Berger, M. S., Tonn, J-C. & Expert Rater Panel, 11.2023, in: LANCET ONCOL. 24, 11, S. e438-e450

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Rha, S. Y., Oh, D-Y., Yañez, P., Bai, Y., Ryu, M-H., Lee, J., Rivera, F., Alves, G. V., Garrido, M., Shiu, K-K., Fernández, M. G., Li, J., Lowery, M. A., Çil, T., Cruz, F. M., Qin, S., Luo, S., Pan, H., Wainberg, Z. A., Yin, L., Bordia, S., Bhagia, P., Wyrwicz, L. S. & KEYNOTE-859 investigators, 11.2023, in: LANCET ONCOL. 24, 11, S. 1181-1195 15 S.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

Dimopoulos, M. A., Merlini, G., Bridoux, F., Leung, N., Mikhael, J., Harrison, S. J., Kastritis, E., Garderet, L., Gozzetti, A., van de Donk, N. W. C. J., Weisel, K. C., Badros, A. Z., Beksac, M., Hillengass, J., Mohty, M., Ho, P. J., Ntanasis-Stathopoulos, I., Mateos, M-V., Richardson, P., Blade, J., Moreau, P., San-Miguel, J., Munshi, N., Rajkumar, S. V., Durie, B. G. M., Ludwig, H., Terpos, E. & International Myeloma Working Group, 07.2023, in: LANCET ONCOL. 24, 7, S. e293-e311

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

Ludwig, H., Terpos, E., van de Donk, N., Mateos, M-V., Moreau, P., Dimopoulos, M-A., Delforge, M., Rodriguez-Otero, P., San-Miguel, J., Yong, K., Gay, F., Einsele, H., Mina, R., Caers, J., Driessen, C., Musto, P., Zweegman, S., Engelhardt, M., Cook, G., Weisel, K., Broijl, A., Beksac, M., Bila, J., Schjesvold, F., Cavo, M., Hajek, R., Touzeau, C., Boccadoro, M. & Sonneveld, P., 06.2023, in: LANCET ONCOL. 24, 6, S. e255-e269

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

Otth, M., Brack, E., Kearns, P. R., Kozhaeva, O., Ocokoljic, M., Schoot, R. A., Vassal, G. & Essential Medicines Group, 12.2022, in: LANCET ONCOL. 23, 12, S. 1537-1546 10 S.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial

Nitz, U., Gluz, O., Graeser, M., Christgen, M., Kuemmel, S., Grischke, E-M., Braun, M., Augustin, D., Potenberg, J., Krauss, K., Schumacher, C., Forstbauer, H., Reimer, T., Stefek, A., Fischer, H. H., Pelz, E., Zu Eulenburg, C., Kates, R., Wuerstlein, R., Kreipe, H. H., Harbeck, N. & WSG-ADAPT investigators, 05.2022, in: LANCET ONCOL. 23, 5, S. 625-635 11 S.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial

Wen, P. Y., Stein, A., van den Bent, M., De Greve, J., Wick, A., de Vos, F. Y. F. L., von Bubnoff, N., van Linde, M. E., Lai, A., Prager, G. W., Campone, M., Fasolo, A., Lopez-Martin, J. A., Kim, T. M., Mason, W. P., Hofheinz, R-D., Blay, J-Y., Cho, D. C., Gazzah, A., Pouessel, D., Yachnin, J., Boran, A., Burgess, P., Ilankumaran, P., Gasal, E. & Subbiah, V., 01.2022, in: LANCET ONCOL. 23, 1, S. 53-64 12 S.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study

Saad, F., Efstathiou, E., Attard, G., Flaig, T. W., Franke, F., Goodman, O. B., Oudard, S., Steuber, T., Suzuki, H., Wu, D., Yeruva, K., De Porre, P., Brookman-May, S., Li, S., Li, J., Thomas, S., Bevans, K. B., Mundle, S. D., McCarthy, S. A., Rathkopf, D. E. & ACIS Investigators, 11.2021, in: LANCET ONCOL. 22, 11, S. 1541-1559 19 S.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Alle anzeigen (66)